동종조혈모세포 이식 후 발생한 거대세포바이러스 폐렴에서 Ganciclovir와 Leflunomide 병합치료 경험 1예
- Alternative Title
- Ganciclovir and Leflunomide Combination Therapy for a Patient with Cytomegalovirus Pneumonia after Unrelated Allogenic Stem Cell Transplantation
- Abstract
- Cytomegalovirus (CMV) infection is an important cause of morbidity and mortality among transplant recipients. The first line standard therapy for CMV pneumonia is treatment with a combination of ganciclovir and immunoglobulin. Nevertheless, the mortality of CMV pneumonia is 30~70%. Leflunomide has been recently reported to have novel anti-CMV activity by inhibiting viron assembly. It is also cheaper and is more easily given orally as compared to ganciclovir. We report here on an allogenic stem cell transplant recipient who developed CMV pneumonia that was refractory to ganciclovir and immunoglobulin. The patient was successfully treated with a combination of leflunomide and ganciclovir.
- All Author(s)
- J. H. Lim
; Y. N. Lee
; Y. S. Ryu
; H. J. Kim
; K. H. Kim
; S. H. Kim
; S. C. Lee
; S. B. Bae
; C. K. Kim
; K. T. Lee
; S. K. Park
; J. H. Won
; D. S. Hong
; H. S. Park
; J. S. Park
; Y. K. Lee
- Issued Date
- 2009
- Type
- Article
- Keyword
- Cytomegalovirus; Ganciclovir; Leflunomide
- Publisher
- 대한혈액학회
대한조혈모세포이식학회
대한혈전지혈학회
대한소아혈액종양학회
the Koreans Society of Hematology
the Korean Society of Blood and Marrow Transplantation
the Korean Society on Thrombosis and Hemostasis
the Korean Society of Pediatric Hematolog-Oncology
- ISSN
- 1738-7949
; 2092-9129
- Citation Title
- The Korean journal of hematology
- Citation Volume
- 44
- Citation Number
- 4
- Citation Start Page
- 315
- Citation End Page
- 319
- Language(ISO)
- kor
- DOI
- 10.5045/kjh.2009.44.4.315
- URI
- http://schca-ir.schmc.ac.kr/handle/2022.oak/3213
- 공개 및 라이선스
-
- 파일 목록
-
Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.